The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)"

Semin Thromb Hemost. 2010 Feb;36(1):123-4; author reply 125-7. doi: 10.1055/s-0030-1248731. Epub 2010 Apr 13.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Animals
  • Factor VII / genetics
  • Factor VII Deficiency / diagnosis*
  • Factor VII Deficiency / genetics
  • Female
  • Humans
  • Male
  • Middle Aged
  • Rabbits
  • Thromboplastin / therapeutic use*

Substances

  • Factor VII Padua
  • Factor VII
  • Thromboplastin